Back to search

Rowan University

Study of modified Salinomycin analogs on inhibition of triple negative breast cancer metastasis and invasion

Abstract

dc:description.abstract

Triple negative breast cancer (TNBC) is a more aggressive type of breast cancer which contains faster growth, higher metastasis rate and worse prognosis. The main challenge toward treatment of this type of cancer is being heterogeneous. Recently, Salinomycin (SAL) has been considered as a potential agent for triple negative breast cancer treatment. However, chemical modification of SAL is needed to improve SAL selectivity to cations and decrease its cytotoxicity. The purpose of this study was to evaluate the effect of chemically modified analogs of SAL on the viability, metastasis, Wnt pathway as well as angiogenesis of Triple negative breast cancer (TNBC) cell lines using MTT assay, Western blot and Invasion assay. Obtained results indicated that the tested compounds may have the potential to inhibit angiogenesis, metastasis and alter Wnt signaling pathway. However, more studies are needed to clarify their effects on CSCs, in vivo and moreover, the effects on both tumor and normal cells.

Degree

thesis:*
Name thesis:degree_name
Master of Science (M.S.) in Pharmaceutical Sciences
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Chemistry and Biochemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Malekmarzban, Farnaz
Contributors dc:contributor
  • Subash Jonnalagadda, Ph.D.
  • Manoj Pandey, Ph.D.
  • Kandalam Ramanujachary, Ph.D.

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://rdw.rowan.edu/etd/3264

Chain of custody

source
Harvested from
Rowan University
Base URL
rdw.rowan.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Malekmarzban, Farnaz. Study of modified Salinomycin analogs on inhibition of triple negative breast cancer metastasis and invasion. Thesis thesis, https://rdw.rowan.edu/etd/3264